The Oncology Institute, Inc. TOI Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other accrued liabilities?
- The Oncology Institute, Inc. (TOI) reported other accrued liabilities of $24.3M in Q1 2026.
- How has The Oncology Institute, Inc.'s other accrued liabilities changed year-over-year?
- The Oncology Institute, Inc.'s other accrued liabilities increased by 3.7% year-over-year, from $23.43M to $24.3M.
- What is the long-term trend for The Oncology Institute, Inc.'s other accrued liabilities?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s other accrued liabilities has grown at a 10.3% compound annual growth rate (CAGR), from $13.92M to $20.64M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.